[ad_1]
The first meeting of the medical expert advisory committee … “Kick-off personality”
About 20 people attended … It is expected to discuss the standards for the introduction of vaccines abroad.
[연합뉴스TV 제공]
(Seoul = Yonhap News) Reporter Lee Do-yeon and Kim Ye-na = The government is holding an expert meeting for the introduction of a vaccine amid competition for the development of vaccines and treatments for the novel coronavirus infection (Corona 19) around the world.
Taeho Yoon, head of the Accident Control Headquarters, said at the Corona 19 situation briefing held at the Sejong Government Complex on the 12th, “The Corona 19 Vaccine Introduction Advisory Committee will be held this night regarding the purchase of vaccines. ”
“I know that the advisory committee is forming for the first time,” Yun said. “I know this is the first meeting today, but I know that the content of the standard setting related to the introduction of vaccines is primarily discussed.”
“The committee is in contact and negotiating with various (vaccine development) companies,” he said. “There is a process where the committee decides on a company based on what a relatively stable vaccine is.”
The meeting is scheduled to take place somewhere in Seoul, and about 20 vaccine-related experts are known to attend, including the medical community.
As this is the first committee to be attended by a large number of experts, the meeting is expected to explain the vaccine purchase negotiation process and discuss the direction of the future operation of the committee.
Furthermore, as the government previously announced that it is negotiating with Pfizer, AstraZeneca, NovaVax, Johnson & Johnson, and Modena, the company’s clinical vaccine process, safety and effectiveness, etc.
A government official said, “Today’s meeting is a beginning to meet with experts” and said: “We will review and discuss information such as the safety and efficacy of the vaccine currently being developed, the price, the transportation and the prognosis of the vaccine. Delivery time.
Currently, the government is moving closer to the ‘two-way strategy’ of contracting individual contracts with global pharmaceutical companies while strengthening international cooperation to quickly secure the Corona 19 vaccine when it is developed.
Specifically, the plan is to secure 10 million vaccines through the COVAX facility, an international project for the joint purchase and distribution of vaccines, and 20 million through individual negotiations with global companies.
Regarding the vaccines developed by Pfizer, an American pharmaceutical company, and Bioentech, Germany, which recently published positive results from clinical trials, only mentioned that “pre-purchase negotiations with Pfizer are in progress.”
Regarding the timing of the vaccine contract, he said: “It is still difficult to say when the final pre-contract will be made.” “He added.
<저작권자 (c) 연합 뉴스,
Unauthorized reproduction-redistribution prohibited>
2020/11/12 12:07 Sent
